FACTX Holdings Information

FACTX is a mutual fund with a total of 155 individual holdings. The top holdings are Eli Lilly and Company stock at 7.66%, Danaher at 6.75%, Thermo Fisher Scientific at 6.31%, UnitedHealth Group at 4.17%, and Johnson & Johnson at 3.78%.

Total Holdings

155

Top 10 Percentage

40.48%

Asset Class

Equity

Fund Category

Health

Assets

3.34B

Forward PE Ratio

12.93

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	7.66%	208,000
2	DHR	Danaher Corporation	6.75%	1,080,000
3	TMO	Thermo Fisher Scientific Inc.	6.31%	342,500
4	UNH	UnitedHealth Group Incorporated	4.17%	314,000
5	JNJ	Johnson & Johnson	3.78%	460,000
6	ABBV	AbbVie Inc.	3.62%	450,000
7	ARGX	argenx SE	2.09%	76,500
8	MRK	Merck & Co., Inc.	2.09%	500,000
9	WST	West Pharmaceutical Services, Inc.	2.06%	188,400
10	ASND	Ascendis Pharma A/S	1.95%	250,000
11	ALNY	Alnylam Pharmaceuticals, Inc.	1.78%	270,000
12	A	Agilent Technologies, Inc.	1.75%	395,000
13	VTRS	Viatris Inc.	1.67%	2,960,000
14	NTRA	Natera, Inc.	1.65%	192,290
15	GH	Guardant Health, Inc.	1.48%	285,000
16	TXG	10x Genomics, Inc.	1.45%	954,913
17	RVMD	Revolution Medicines, Inc.	1.44%	240,300
18	WAT	Waters Corporation	1.43%	118,000
19	ORKA	Oruka Therapeutics, Inc.	1.32%	428,000
20	EBR: UCB	UCB SA	1.32%	160,000
21	CVS	CVS Health Corporation	1.29%	385,000
22	GILD	Gilead Sciences, Inc.	1.25%	300,000
23	BSX	Boston Scientific Corporation	1.23%	820,000
24	RGEN	Repligen Corporation	1.22%	270,000
25	ELVN	Enliven Therapeutics, Inc.	1.18%	670,000

Showing 25 of 155 holdings

Subscribe to see the full list

Activate Now

As of Jul 31, 2026